12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
12-week, double-blind, placebo-controlled, multicenter, randomized study designed to evaluate the safety and efficacy of 40 mg/day istradefylline compared with placebo in subjects with OFF phenomena advanced PD who were treated with levodopa/carbidopa.
Epistemonikos ID: 4735af93fbbc4acd2c6d0f6c47ccbc4189d5fb4c
First added on: May 04, 2024